Clinical Trial Update: Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients

View source ↗

Summary

This completed clinical trial evaluated the safety and efficacy of extended adjuvant letrozole (Femara) in breast cancer patients. The sponsor was Novartis Phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer, Letrozole | Status: COMPLETED